Discusses Strategic Focus on Izicopan for ANCA-Associated Vasculitis and Renal Diseases May 8, 2026 8:30 AM EDTCompany ...

Discusses BGE-102 Clinical Results and Development Strategy for Cardiovascular and Retinal Disease May 8, 2026 12:30 PM ...

Verizon stock outlook: analysts bullish on fiber growth, Frontier synergies, and a 6% dividend despite leverage risks.

Equities maintain a "risk-on" rally, defying the market disconnect from elevated oil prices and rising interest rate ...

Engie SA is downgraded to neutral after a period of strong returns and increased valuation risk. Learn more about ENGIY stock ...

Metals have been trading in confusion since the beginning of the war, with particular inflation and price action dynamics ...

Q1 2026 earnings call: workers’ comp growth, margin gains, and raised 2026 revenue/EBITDA/FCF guidance—get key takeaways now.

I think it was just a typical Vitalhub quarter. It was a steady quarter, and we're happy with where we are. I think we're well ahead of our budgets and our plans, and we're excited to just keep moving ...

Artiva Biotherapeutics (ARTV) is maintained as a "Buy," driven by FDA alignment for a single phase 3 trial of AlloNK plus ...

Enbridge ENB Q1 2026 earnings call: guidance reaffirmed, record volumes, growth projects, debt targets, and key risks (FX, Line 5, exports).

A fire broke out at PBF ​Energy's Chalmette refinery ​in Louisiana following a large explosion, but the blaze was quickly ...

Gold ​futures closed higher, holding above $4,700/oz, and some analysts say downside risks for the metal are limited as ...